ZVRA News & Events

Zevra Therapeutics announced an agreement under which Commave Therapeutics will purchase Zevra's serdexmethylphenidate portfolio, including AZSTARYS and KP1077, for $50 million. Zevra and Commave had previously entered into a 2019 license agreement under which Zevra granted Commave an exclusive license to certain SDX products. In 2024, Commave initiated litigation in Delaware Chancery Court against Zevra, and as part of today's purchase agreement between the companies, the parties mutually agreed to settle the dispute. Prior to entering into the agreement, the Company repaid the principal balance on its $63 million term loan in full, resulting in a strong, debt-free balance sheet and enhanced financial and strategic flexibility.

The major averages closed little changed as markets traded with a more constructive tone in concert with oil prices pulling back. Oil prices, which had surged above $100 and briefly approached $120 per barrel during the escalation of the Iran conflict, are now coming back in after comments from Donald Trump suggesting the military operation could conclude sooner than previously expected. Meanwhile, CBS News' Jennifer Jacobs reported that there are indications Iran is taking steps to deploy mines in the Strait of Hormuz.In other commodity news, gold prices continue their surge amid market volatility. Despite having an up-and-down 2026, the commodity is climbing towards record highs once again.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Nvidiaand Thinking Machines Lab announced a gigawatt-scale strategic partnershipBioNTechannounced plans for anto be established and led by BioNTech co-founders Prof. Ugur Sahin, M.D., and Prof. Ozlem Tureci, M.D.HP Enterprisereportedand provided guidance for Q1 and FY26Kohl'sreportedbut guided for a decrease in Q1 comp salesVail Resortsreportedand cut its FY26 resort reported EBITDA view2. WALL STREET CALLS:Qualcommat Underperform at BofACrowdStriketo Overweight at Morgan StanleyRivianto Buy at TD Cowen into R2 launchNovo Nordiskto Hold at TD CowenB. RileyStrategywith Buy on "unmatched scale"3. AROUND THE WEB:Boeingwill delay deliveries of some e737 MAX planes amid wiring flaws, WSJ reportsExxon Mobilis planning to move its legal home to Texas from New Jersey in a move meant to protect the company from shareholder "abuse," WSJ saysRio Tintois in talks with Mongolia over financial terms at the massive Oyu Tolgoi copper mine, with the government seeking lower loan interest costs and the removal of Rio's annual management fee, WSJ reportsAppleincreased its iPhone production in India by 53% last year and now makes a total of 25% of its devices there, Bloomberg saysAmazon'secommerce business has requested a large group of engineers to meet on Tuesday for a "deep dive" into the influx of outages, with the company stating there has been a "trend of incidents" characterized by a "high blast radius" and "Gen-AI assisted changes," FT reports4. MOVERS:Zevra Therapeuticsgains after, with EPS and revenue beating consensusCapricorincreases after announcing the establishment of a new PDUFANiohigher in New York afterand providing guidance for Q1Centenefalls afterand announcing its ACA enrollment is "still in line" with expectations"Crispr Therapeuticslower after announcing a5. EARNINGS/GUIDANCE:ABM, with CEO Scott Salmirs commenting, "ABM is off to a solid start to FY26"Custom Truck One Source, with EPS beating consensusUnited Natural Foodsand provided guidance for FY26UWM Holdingsraised itsPriority Technologyand provided guidance for FY26INDEXES:The Dow fell 34.29, or 0.072%, to 47,706.51, the Nasdaq gained 1.16, or 0.0051%, to 22,697.10, and the S&P 500 advanced 14.51, or 0.21%, to 6,781.48.

The major averages were higher near noon as markets are trading with a more constructive tone. Investors are reacting to a reversal in the energy shock that dominated markets earlier in the week. Oil prices, which had surged above $100 and briefly approached $120 per barrel during the escalation of the Iran conflict, are now pulling back after comments from Donald Trump suggesting the military operation could conclude sooner than previously expected.Meanwhile, gold prices continue their surge amid market volatility, as the "safe haven" asset rose nearly 2%. Despite having an up-and-down 2026, the commodity is climbing towards record highs once again.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Nvidiaintends to launch an open-source AI agent platform,BioNTechannounced plans forto be established and led by BioNTech co-founders Prof. Ugur Sahin, M.D., and Prof. Ozlem Tureci, M.D.HP Enterprisereportedand provided guidance for Q1 and FY26Kohl'sreportedbut guided for a decrease in Q1 comp salesVail Resortsreportedand cut its FY26 resort reported EBITDA view2. WALL STREET CALLS:Qualcommat Underperform at BofACrowdStriketo Overweight at Morgan StanleyRivianto Buy at TD Cowen into R2 launchNovo Nordiskto Hold at TD CowenB. RileyStrategywith Buy on "unmatched scale"3. AROUND THE WEB:Exxon Mobilis planning to move its legal home to Texas from New Jersey in a move meant to protect the company from shareholder "abuse," WSJ saysRio Tintois in talks with Mongolia over financial terms at the massive Oyu Tolgoi copper mine, with the government seeking lower loan interest costs and the removal of Rio's annual management fee, WSJ reportsAppleincreased its iPhone production in India by 53% last year and now makes a total of 25% of its devices there, Bloomberg saysAmazon'secommerce business has requested a large group of engineers to meet on Tuesday for a "deep dive" into the influx of outages, with the company stating there has been a "trend of incidents" characterized by a "high blast radius" and "Gen-AI assisted changes," FT reportsA groundstop for all JetBlueflights was canceled within an hour on Tuesday by the U.S. Federal Aviation Administration, FAA, after JetBlue said it resolved a "system outage," Reuters reports4. MOVERS:Zevra Therapeuticsgains after, with EPS and revenue beating consensusCapricorincreases after announcing the establishment of afor dermiocel BLANiohigher in New York afterand providing guidance for Q1Centenefalls afterfor FY26 and announcing its ACA enrollment is "still in line" with expectations"Crispr Therapeuticslower after announcing a5. EARNINGS/GUIDANCE:ABM, with CEO Scott Salmirs commenting, "ABM is off to a solid start to FY26"Custom Truck One Source, with EPS beating consensusUnited Natural Foodsand provided guidance for FY26UWM Holdingsfor Q1Priority Technologyand provided guidance for FY26INDEXES:Near midday, the Dow was up 0.48%, or 229.12, to 47,969.92, the Nasdaq was up 0.58%, or 131.24, to 22,827.19, and the S&P 500 was up 0.39%, or 26.81, to 6,822.80.